Gliflozins in the Management of Cardiovascular Disease
Brigham and Women's Hospital · Thrombolysis in Myocardial Infarction Study Group
Indexed incrossrefpubmed
Abstract
Gliflozins — sodium–glucose cotransporter 2 inhibitors — lower blood glucose and glycated hemoglobin in patients with type 2 diabetes without causing hypoglycemia. The agents also improve cardiac function in patients who have heart failure with or without type 2 diabetes and improve renal function, with few adverse effects.
Citation impact
248
total citations
- FWCI
- 30.50
- Percentile
- 100%
- References
- 84
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Medicine
- Glycated hemoglobin
- Hypoglycemia
- Type 2 diabetes
- Diabetes mellitus
- Renal function
- Adverse effect
- Heart failure
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.